These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
678 related items for PubMed ID: 19493458
1. Clinical study of 39 Chinese patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Ma KJ, Li N, Wang HT, Chu JM, Fang PH, Yao Y, Ma J, Hua W, Zhang S, Wang FZ, Li Z, Pu JL. Chin Med J (Engl); 2009 May 20; 122(10):1133-8. PubMed ID: 19493458 [Abstract] [Full Text] [Related]
2. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up. Pezawas T, Stix G, Kastner J, Schneider B, Wolzt M, Schmidinger H. Int J Cardiol; 2006 Mar 08; 107(3):360-8. PubMed ID: 16503259 [Abstract] [Full Text] [Related]
3. [Clinical and ECG features of arrhythmogenic right ventricular cardiomyopathy: a retrospective analysis of 31 cases]. Pu JL, Wang HT, Liu TK, Ma KJ, Li N, Yao Y, Chu JM, Fang PH, Ma J, Hua W, Zhang S, Wang FZ. Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan 08; 35(1):24-7. PubMed ID: 17386159 [Abstract] [Full Text] [Related]
4. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, Salerno JU, Igidbashian D, Raviele A, Disertori M, Zanotto G, Verlato R, Vergara G, Delise P, Turrini P, Basso C, Naccarella F, Maddalena F, Estes NA, Buja G, Thiene G. Circulation; 2003 Dec 23; 108(25):3084-91. PubMed ID: 14638546 [Abstract] [Full Text] [Related]
6. Arrhythmogenic right ventricular dysplasia: a United States experience. Dalal D, Nasir K, Bomma C, Prakasa K, Tandri H, Piccini J, Roguin A, Tichnell C, James C, Russell SD, Judge DP, Abraham T, Spevak PJ, Bluemke DA, Calkins H. Circulation; 2005 Dec 20; 112(25):3823-32. PubMed ID: 16344387 [Abstract] [Full Text] [Related]
7. Serial reevaluation for ARVD/C is indicated in patients presenting with left bundle branch block ventricular tachycardia and minor ECG abnormalities. Kiès P, Bootsma M, Bax JJ, Zeppenfeld K, van Erven L, Wijffels MC, van der Wall EE, Schalij MJ. J Cardiovasc Electrophysiol; 2006 Jun 20; 17(6):586-93. PubMed ID: 16836703 [Abstract] [Full Text] [Related]
8. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres. Peters S. J Cardiovasc Med (Hagerstown); 2007 Jul 20; 8(7):521-6. PubMed ID: 17568286 [Abstract] [Full Text] [Related]
9. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Corrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, Basso C, Ward D, Boriani G, Ricci R, Piccini JP, Dalal D, Santini M, Buja G, Iliceto S, Estes NA, Wichter T, McKenna WJ, Thiene G, Marcus FI. Circulation; 2010 Sep 21; 122(12):1144-52. PubMed ID: 20823389 [Abstract] [Full Text] [Related]
10. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Wichter T, Paul M, Wollmann C, Acil T, Gerdes P, Ashraf O, Tjan TD, Soeparwata R, Block M, Borggrefe M, Scheld HH, Breithardt G, Böcker D. Circulation; 2004 Mar 30; 109(12):1503-8. PubMed ID: 15007002 [Abstract] [Full Text] [Related]
12. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Dalal D, Jain R, Tandri H, Dong J, Eid SM, Prakasa K, Tichnell C, James C, Abraham T, Russell SD, Sinha S, Judge DP, Bluemke DA, Marine JE, Calkins H. J Am Coll Cardiol; 2007 Jul 31; 50(5):432-40. PubMed ID: 17662396 [Abstract] [Full Text] [Related]
13. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Dalal D, Molin LH, Piccini J, Tichnell C, James C, Bomma C, Prakasa K, Towbin JA, Marcus FI, Spevak PJ, Bluemke DA, Abraham T, Russell SD, Calkins H, Judge DP. Circulation; 2006 Apr 04; 113(13):1641-9. PubMed ID: 16549640 [Abstract] [Full Text] [Related]
14. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD? Wichter T, Paul TM, Eckardt L, Gerdes P, Kirchhof P, Böcker D, Breithardt G. Herz; 2005 Mar 04; 30(2):91-101. PubMed ID: 15875097 [Abstract] [Full Text] [Related]
15. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Schinkel AF. Circ Arrhythm Electrophysiol; 2013 Jun 04; 6(3):562-8. PubMed ID: 23673907 [Abstract] [Full Text] [Related]
16. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Nasir K, Bomma C, Tandri H, Roguin A, Dalal D, Prakasa K, Tichnell C, James C, Spevak PJ, Marcus F, Calkins H. Circulation; 2004 Sep 21; 110(12):1527-34. PubMed ID: 15381658 [Abstract] [Full Text] [Related]
17. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. Bai R, Di Biase L, Shivkumar K, Mohanty P, Tung R, Santangeli P, Saenz LC, Vacca M, Verma A, Khaykin Y, Mohanty S, Burkhardt JD, Hongo R, Beheiry S, Dello Russo A, Casella M, Pelargonio G, Santarelli P, Sanchez J, Tondo C, Natale A. Circ Arrhythm Electrophysiol; 2011 Aug 21; 4(4):478-85. PubMed ID: 21665983 [Abstract] [Full Text] [Related]